Executive Director of the National Primary Health Care Development Agency (NHCDA), Dr Faisal Shuaib, has said that the travel ban on Covishield COVID-19 vaccine which is the same as AstraZeneca vaccine that is produced in India was a temporary release because there are different validation processes that are used for different vaccines. According to Shuaib: “The European Union(EU) is not banning permanently or failing to recognise AstraZeneca from India. “It is just that the Indian authorities have to also go through that process to get approved. “The World Health Organization (WHO) actually came out very clearly to clear the air that it doesn’t mean that there is any inferiority in terms of the quality of the vaccination”. Our reporter joined the train to and fro Lagos from Ibadan and tells his experience in this report…FG says travel ban FG says travel ban

Source: Nigerian Tribune July 07, 2021 15:22 UTC